NCT00159237View on ClinicalTrials.gov

GR Defect in Peripheral Blood Mononuclear Cells in COPD

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
PROCEDURE

blood test

Trial Locations (1)

SW3 6LY

Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital, London

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Imperial College London

OTHER

NCT00159237 - GR Defect in Peripheral Blood Mononuclear Cells in COPD | Biotech Hunter | Biotech Hunter